Skip to content

The deal

Type
Funding
Amount
$190M
Structure
Split across two rounds: Series A led by Third Rock and Series B led by Sofinnova Investments, Forbion, Perceptive Xontogeny Venture Fund, and venBio
Status
Closed
Round
Round
Post-money
Not recorded
Region
Not recorded
Date
20 June 2024

As of this development: a later development may record new terms.

Lifecycle

  1. AnnouncedNot recorded
  2. Closed20 June 2024 · This development

Investors in this round

Third Rock Ventures · Lead investor

First round with Marea Therapeutics

Sofinnova Investments · Lead investor

First round with Marea Therapeutics

Forbion · Lead investor

First round with Marea Therapeutics

Perceptive Xontogeny Venture Fund · Lead investor

First round with Marea Therapeutics

venBio · Lead investor

First round with Marea Therapeutics

Ownership and exit

Acquired by Lisata Therapeutics

17 September 2026 · Acquisition · Closed · after 1 round since 2024 · The deal

Minutes shows stakes only when a party discloses them.

The parties

Marea Therapeutics Issuer

2 developments · 2 deals in Minutes

Third Rock Ventures Lead investor

1 development · 1 deal in Minutes

Sofinnova Investments Lead investor

1 development · 1 deal in Minutes

Forbion Lead investor

1 development · 1 deal in Minutes

More in Healthcare

Past 3 months in Activity →